IntriCon Hires Doug Pletcher as Vice President of Medical Business Development
January 16 2019 - 11:00AM
Business Wire
IntriCon Corporation (NASDAQ: IIN), a designer,
developer, manufacturer and distributor of miniature and
micro-miniature body-worn devices, today announced that it has
hired Doug Pletcher as Vice President of Medical Business
Development.
Pletcher has more than 25 years of executive management and
business development experience in the medical device industry. In
this new role, Pletcher is responsible for sales and marketing of
new product platforms into the medical biotelemetry market. Prior
to joining IntriCon, he served as Vice President of Business
Development for Heraeus Medical Components, where he was
responsible for all business development activities for
Interventional Finished Devices.
“We are excited to welcome Doug to the IntriCon team,” said Mark
S. Gorder, IntriCon’s president and chief executive officer. “We
identified the need for more investment and resources to expand our
medical business. Doug’s more than two decades in the industry will
help us leverage our micro-miniaturization, digital signal
processing and ultra-low power wireless core competencies to grow
this business. His comprehensive background in engineering,
marketing and clinical is a perfect mix of expertise to drive
future growth and diversification.”
Said Pletcher, “I am excited to join IntriCon, a company with a
deep breadth of proprietary technology and a compelling future. I
look forward to working with the team to advance the company’s
growth strategy and drive shareholder value.”
About IntriCon CorporationHeadquartered in Arden Hills,
Minn., IntriCon Corporation designs, develops and manufactures
miniature and micro-miniature body-worn devices. These advanced
products help medical, healthcare and professional communications
companies meet the rising demand for smaller, more intelligent and
better-connected devices. IntriCon has facilities in the United
States, Asia, the United Kingdom and Europe. The company’s common
stock trades under the symbol “IIN” on the NASDAQ Global Market.
For more information about IntriCon, visit www.intricon.com.
Forward-Looking StatementsStatements made in this release
and in IntriCon’s other public filings and releases that are not
historical facts or that include forward-looking terminology,
including estimates of future results, are “forward-looking
statements” within the meaning of the Securities Exchange Act of
1934, as amended. These forward-looking statements may be affected
by known and unknown risks, uncertainties and other factors that
are beyond IntriCon’s control, and may cause IntriCon’s actual
results, performance or achievements to differ materially from the
results, performance and achievements expressed or implied in the
forward-looking statements. These risks, uncertainties and other
factors are detailed from time to time in the company’s filings
with the Securities and Exchange Commission, including the Annual
Report on Form 10-K for the year ended December 31, 2017. The
company disclaims any intent or obligation to publicly update or
revise any forward-looking statements, regardless of whether new
information becomes available, future developments occur or
otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190116005541/en/
At IntriCon:Scott Longval,
CFO651-604-9526slongval@intricon.com
At Padilla:Matt
Sullivan612-455-1709matt.sullivan@padillaco.com
Intricon (NASDAQ:IIN)
Historical Stock Chart
From Apr 2024 to May 2024
Intricon (NASDAQ:IIN)
Historical Stock Chart
From May 2023 to May 2024